世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
獣医感染症診断市場：技術（免疫診断、分子診断（PCR））、動物（コンパニオン、食用動物）、エンドユーザー（リファレンスラボ、病院、診療所、大学）別 - 2026年までの世界市場予測Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing animals), End User (Reference Labs, Hospital, Clinics, Universities) - Global Forecast to 2026 動物用感染症診断薬市場は、2021年の推定17億米ドルから2026年には26億米ドルに達し、CAGR9.0％で推移すると予測されています。動物用感染症診断の成長を促す主な要因としては、迅速検査に対する需要の高まり、技... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリー動物用感染症診断薬市場は、2021年の推定17億米ドルから2026年には26億米ドルに達し、CAGR9.0％で推移すると予測されています。動物用感染症診断の成長を促す主な要因としては、迅速検査に対する需要の高まり、技術の進歩の高まり、コンパニオンアニマル人口の増加、ペット保険需要の高まり、越境・人獣共通感染症の発生率の高まり、先進国での獣医開業医の増加、疾病管理・疾病予防対策の高まり、動物保健支出の増加などが挙げられます。動物由来食品の消費量増加に伴い、動物由来食品の品質を確保するために、動物の疾病を効果的に診断・治療する必要性が高まっています。動物由来食品のニーズの高まりは、感染症の可能性をさらに高めるため、今後数年間、この市場の成長を促進するものと考えられます。しかし、ペットの飼育費用の高騰は、飼い主が動物病院を訪れる回数に直接影響するため、この市場の成長を抑制しています。また、動物病院での処置に対する診療報酬の欠如も、動物用感染症診断薬の普及を妨げる要因となっています。特に発展途上国では、熟練した獣医師と診断インフラの不足が、獣医師による高度な診断ソリューションの導入を阻む大きな要因の一つとなっています。COVID-19の最初の発生以来、複数の国で哺乳類におけるSARS-CoV-2の感染が報告されています。世界中でCOVID-19の流行が増加しているため、ヒトと動物に対する検査量は増加し続けています。このため、検査機関やレファレンス・ラボラトリーは、新しく改良された動物検査を開発する必要に迫られています。パンデミックの最盛期には、多くの国で伴侶動物の獣医療に必要な緊急処置のみが行われるように規定されていた。しかし、COVID-19のパンデミックは、数ヵ月後には獣医の訪問回数が増え、日常診療の遅れもなくなったことから、予測期間中は動物用感染症診断薬市場に最小限の影響しか与えないと予想されます。 動物用感染症診断薬の世界市場において、予測期間中、免疫診断薬が最大のシェアを占める 技術別に見ると、動物用感染症診断薬の世界市場は、免疫診断薬、分子診断薬、その他の技術に区分されます。獣医師、ペットオーナー、家畜生産者がこの技術をより好むことが、免疫診断分野の大きなシェアに寄与しています。早期かつ正確な診断に対する需要の高まり、社内検査に対する嗜好の高まり、免疫診断の用途拡大などが、このアプリケーション分野の成長を支えています。 2020年の動物用感染症診断の世界市場はコンパニオンアニマルセグメントが独占 動物の種類に基づき、世界の動物用感染症診断薬市場はコンパニオンアニマルと食用動物に区分されます。2020年、コンパニオンアニマルセグメントは、世界の動物用感染症診断薬市場で最大のシェアを占めています。このセグメントの成長の背景には、ペット飼育の増加（特に先進国）、ペット保険の普及率の上昇、世界的な獣医開業医の増加、動物疾病管理・疾病予防対策の強化があります。 動物用感染症診断薬市場の主要なエンドユーザーは動物用リファレンスラボです。 動物用感染症診断薬の世界市場は、エンドユーザーに基づき、動物用レファレンスラボ、動物病院・クリニック、POC検査・院内検査、動物用研究機関・大学に区分されます。2020年、動物用感染症診断薬市場の主要エンドユーザーは、動物用レファレンスラボラトリーであった。このセグメントの大きなシェアは、主に獣医師の数の増加、動物病院の数の増加、小動物および大動物病院からリファレンスラボで診断用に受け取るサンプルの数の増加によるものであると思われる。ペットの飼い主の間では、日常的な予防医療に関する意識が高まっており、市場の成長をさらに後押しすると予想されます。 予測期間において、北米が動物用感染症診断薬の世界市場で最大のシェアを占めています。 予測期間中、北米は世界の動物用感染症診断薬市場で最大のシェアを占めています。北米の動物用感染症診断市場の成長は、コンパニオンアニマルや食用動物の人口増加、肉・乳製品消費の増加、技術的に高度な動物用標準研究所の利用、動物医療支出の増加、ペット保険の適用範囲の拡大が特徴です。 主な参加者の内訳は、以下の通り。 - 企業タイプ別：Tier1～60％、Tier2～30％、Tier3～10％。 - 役職別 - Cレベル-30％、ディレクターレベル-50％、その他-20 - 地域別：北米-45％、欧州-15％、アジア太平洋-25％、中南米-10％、中東・アフリカ-5 動物用感染症診断薬市場の主要プレイヤー 動物用診断薬市場の主なプレイヤーは、IDEXX Laboratories, Inc.(米国)、Zoetis, Inc.(米国)、Thermo Fisher Scientific, Inc.(米国）、Virbac（フランス）、bioMérieux SA（フランス）、Heska Corporation（米国）、IDvet（フランス）、NEOGEN Corporation（米国）、QIAGEN N.V. （INDICAL Bioscienceの一部）（欧州）、Randox Laboratories Ltd.（米国）、Thermo Fisher Scientific, Inc.(米国)（欧州）、Thermo Fisher Scientific, Inc.(英国)、Agrolabo S.p.A.（イタリア）、Bio-Rad Laboratories（米国）、Bionote, Inc.(韓国）、Biogal Galed Labs（イスラエル）、BioChek（オランダ）、（イギリス）、Biopanda Reagents（イギリス）、URIT Medical Electronic Co.Ltd.(中国）、MEGACOR Diagnostik GmbH（オーストリア）、LIVET（英国）、INDICAL BIOSCIENCE GmbH（ドイツ）、Fassisi GmbH（ドイツ）、Alvedia（フランス）、SKYER, Inc.(韓国)、Shenzhen Bioeasy Biotechnology Co.(中国)、Precision Biosensor (米国)。 調査対象範囲 当レポートでは、動物用感染症診断薬市場を分析し、技術、動物種、エンドユーザー、地域などの様々なセグメントに基づいて、同市場の市場規模および今後の成長性を推定することを目的としています。また、市場で入手可能な様々な動物用感染症診断薬の製品ポートフォリオマトリックスも掲載しています。また、同市場の主要企業の競争力分析も行っており、企業プロファイル、製品提供、主要な市場戦略も併せて掲載しています。 本レポートを購入する理由 本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができ、ひいては、より大きな市場シェアを獲得するのに役立つことでしょう。本レポートを購入された企業は、下記の戦略のいずれか、または組み合わせて使用することで、市場での地位を強化することができます。 本レポートでは、以下のポイントについて考察しています。 - 市場浸透度。動物用感染症診断の世界市場における上位企業が提供する製品ポートフォリオに関する包括的な情報。本レポートでは、この市場を技術別、動物タイプ別、エンドユーザー別に分析しています。 - 製品の強化/革新。獣医感染症診断の世界市場における今後の動向と製品の上市に関する詳細な洞察。 - 市場開発。技術別、動物種別、エンドユーザー別の有利な新興市場に関する包括的な情報です。 - 市場の多様化。新製品や製品の強化、成長地域、最近の開発、世界の動物用感染症診断市場における投資に関する徹底的な情報。 - 競争力の評価。世界の動物用感染症診断市場における主要企業の市場シェア、成長戦略、製品オファリング、競合のリーダーシップマッピング、能力に関する詳細な評価。
SummaryThe veterinary infectious disease diagnostics market is expected to reach USD 2.6 billion by 2026 from an estimated USD 1.7 billion in 2021, at a CAGR of 9.0%. The major factors driving the growth of the veterinary infectious disease diagnostics include the growing demand for rapid tests, rising technological advancements, growth in companion animal population, rising demand for pet insurance, increasing incidence of transboundary and zoonotic diseases, rising number of veterinary practitioners in developed economies, increasing disease control & disease prevention measures, and growing animal health expenditure. With the growing consumption of animal-derived food products, there is a rising need for the effective diagnosis and treatment of diseases in animals to ensure the quality of animal-derived food products. The rising need for animal-derived food products will further increase the chances for infections, thereby driving the growth of this market in the coming years. However, high pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market and the lack of reimbursement for veterinary procedures is another factor limiting the uptake of veterinary infectious disease diagnostics. The lack of skilled veterinarians and diagnostics infrastructure, especially in developing countries, is one of the major challenges limiting the uptake of advanced diagnostic solutions among veterinarians. Table of Contents
1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION & SCOPE 41
1.2.1 INCLUSIONS & EXCLUSIONS 41
1.2.2 MARKET SEGMENTATION 42
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION 42
1.2.3 YEARS CONSIDERED FOR THE STUDY 43
1.3 CURRENCY 43
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 43
1.4 STAKEHOLDERS 44
1.5 SUMMARY OF CHANGES 44
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 47
2.1.1.1 Key data from secondary sources 48
2.1.2 PRIMARY DATA 48
FIGURE 3 PRIMARY SOURCES 48
2.1.2.1 Key data from primary sources 49
2.1.2.2 Insights from primary experts 50
2.1.2.3 Key industry insights 50
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 50
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION 51
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION 51
2.2 MARKET SIZE ESTIMATION 52
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 53
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020) 53
FIGURE 10 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: FOOD-PRODUCING ANIMALS DIAGNOSTICS MARKET (2020) 54
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2021–2026) 55
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 56
FIGURE 13 TOP-DOWN APPROACH 56
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 57
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY 57
2.4 MARKET SHARE ANALYSIS 58
2.5 ASSUMPTIONS FOR THE STUDY 58
2.6 LIMITATIONS 58
2.7 RISK ASSESSMENT 59
TABLE 2 RISK ASSESSMENT: VETERINARY INFECTIOUS DISEASE
DIAGNOSTICS MARKET 59
3 EXECUTIVE SUMMARY 60
FIGURE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION) 60
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION) 61
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 61
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 62
4 PREMIUM INSIGHTS 64
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW 64
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE
THE MARKET GROWTH 64
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020) 65
FIGURE 20 THE VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020 65
4.3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 21 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD 66
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION (2019–2026) 67
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 67
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 67
FIGURE 23 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 24 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.2.1 MARKET DRIVERS 69
5.2.1.1 Rising demand for animal-derived food products 69
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT & MILK IN DEVELOPED AND DEVELOPING COUNTRIES 69
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 70
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018 70
5.2.1.2 Increasing companion animal population 71
5.2.1.3 Rising demand for pet insurance and the subsequent growth in animal health expenditure 71
TABLE 5 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020 72
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019 72
5.2.1.4 Growing number of veterinary practitioners in developed economies 73
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018 73
5.2.1.5 Increasing disease control & disease prevention measures 73
5.2.1.6 Rising incidence of transboundary & zoonotic diseases 74
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 74
5.2.1.7 Growing demand for advanced diagnostic devices 75
5.2.2 MARKET RESTRAINTS 76
5.2.2.1 Rising pet care costs 76
5.2.2.2 High costs of veterinary diagnostic tests 77
5.2.3 MARKET OPPORTUNITIES 77
5.2.3.1 Increasing use of PCR-testing panels for COVID-19 testing in animals 77
5.2.3.2 Untapped emerging economies 78
5.2.4 MARKET CHALLENGES 78
5.2.4.1 Shortage of veterinary practitioners in developing markets 78
5.2.4.2 Lack of animal healthcare awareness in emerging countries 79
TABLE 8 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY,
2005 VS. 2014 VS. 2018 79
5.3 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 80
TABLE 9 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS- COV-2 (COVID-19) INFECTIONS IN ANIMALS 80
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION,
JANUARY–JUNE 2020 81
5.4 INDUSTRY TRENDS 81
5.4.1 RISING VEGAN POPULATION 81
5.4.2 ADOPTION OF WEB MONITORING AND OTHER DIGITAL AIDS TO DETECT EMERGING INFECTIOUS DISEASES IN ANIMALS 82
5.4.3 EXPANSIVE GROWTH IN VETERINARY BUSINESSES 82
5.5 VALUE CHAIN ANALYSIS 83
FIGURE 28 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 83
5.6 ECOSYSTEM MARKET MAP 83
FIGURE 29 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS 84
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:
ECOSYSTEM MARKET 84
5.7 PORTER’S FIVE FORCES ANALYSIS 85
TABLE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
5.7.1 THREAT OF NEW ENTRANTS 85
5.7.2 THREAT OF SUBSTITUTES 86
5.7.3 BARGAINING POWER OF SUPPLIERS 86
5.7.4 BARGAINING POWER OF BUYERS 86
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.8 PRICING ANALYSIS 87
TABLE 11 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD) 87
5.9 PATENT ANALYSIS 87
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS 88
5.9.2 PATENT PUBLICATION TRENDS (2011–DECEMBER 2021) 88
5.9.3 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PATENTS (JANUARY
2011–DECEMBER 2021) 89
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2011–DECEMBER 2021) 90
5.10 TECHNOLOGICAL ANALYSIS 90
5.10.1 KEY TECHNOLOGY 90
5.10.1.1 Development of portable instruments for POC diagnostic services 90
TABLE 12 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS 90
5.10.2 ADJACENT TECHNOLOGY 91
5.10.2.1 Development of rapid and sensitive veterinary diagnostic kits 91
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY 92
6.1 INTRODUCTION 93
TABLE 13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 93
6.2 IMMUNODIAGNOSTICS 93
TABLE 14 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET 94
TABLE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 95
6.2.1 LATERAL FLOW ASSAYS 96
6.2.1.1 Lateral flow assays offer rapid results & accurate diagnosis 96
TABLE 17 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
6.2.2 ELISA TESTS 97
6.2.2.1 ELISA tests have gained widespread popularity in the market owing to their efficacy and accurate validation of results 97
TABLE 18 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
6.2.3 OTHER IMMUNODIAGNOSTIC PRODUCTS 98
TABLE 19 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
6.3 MOLECULAR DIAGNOSTICS 99
TABLE 20 KEY VETERINARY MOLECULAR DIAGNOSTICS PRODUCTS
AVAILABLE IN THE MARKET 100
TABLE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 101
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 101
6.3.1 POLYMERASE CHAIN REACTION (PCR) TESTS 102
6.3.1.1 PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals 102
TABLE 23 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
6.3.2 MICROARRAYS 103
6.3.2.1 Technological advancements and the increasing incidence of infectious diseases are factors supporting the growth of this market 103
TABLE 24 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
6.3.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 104
TABLE 25 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
6.4 OTHER TECHNOLOGIES 105
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 105
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE 106
7.1 INTRODUCTION 107
TABLE 27 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 107
7.2 COMPANION ANIMALS 107
TABLE 28 POPULATION OF COMPANION ANIMALS, BY COUNTRY,
2012–2019 (MILLION) 108
TABLE 29 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 108
TABLE 30 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION) 109
7.2.1 DOGS 109
7.2.1.1 The pet dog population has grown significantly in recent years 109
TABLE 31 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS 110
TABLE 32 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS 110
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
7.2.2 CATS 115
7.2.2.1 Increasing pet cat population to drive the market growth 115
TABLE 34 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS 115
TABLE 35 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS 115
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS,
BY COUNTRY, 2019–2026 (USD MILLION) 119
7.2.3 HORSES 119
7.2.3.1 Research programs on horse health awareness is a major factor driving the demand for infection diagnostics for this segment 119
TABLE 37 HORSE POPULATION, BY REGION, 2014–2017 (USD MILLION) 120
TABLE 38 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES 120
TABLE 39 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES 121
TABLE 40 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES,
BY COUNTRY, 2019–2026 (USD MILLION) 124
7.2.4 OTHER COMPANION ANIMALS 124
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 125
7.2.5 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY INFECTION TYPE 125
TABLE 42 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 126
7.2.5.1 Viral infections 126
7.2.5.1.1 The highly contagious nature of viral diseases is a major factor driving the demand for infection diagnostics in companion animals 126
TABLE 43 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS 127
TABLE 44 VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 128
7.2.5.2 Bacterial infections 128
7.2.5.2.1 The bacterial infections segment accounted for the largest share of the market in 2020 128
TABLE 45 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS 129
TABLE 46 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 130
7.2.5.3 Parasitic infections 130
7.2.5.3.1 Rising incidence of worm infestation in companion animals to support the growth of this market 130
TABLE 47 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS 131
TABLE 48 PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 132
7.2.5.4 Other infections 132
TABLE 49 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS 133
TABLE 50 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS 133
TABLE 51 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION) 133
7.3 FOOD-PRODUCING ANIMALS 134
7.3.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE 134
TABLE 52 POPULATION OF FOOD-PRODUCING ANIMALS IN THE US,
2012 TO 2019 (MILLION) 134
TABLE 53 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 134
TABLE 54 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 135
7.3.1.1 Cattle 135
7.3.1.1.1 Growing demand for meat & dairy products to support the growth of this segment 135
TABLE 55 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE 136
TABLE 56 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE 136
TABLE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE,
BY COUNTRY, 2019–2026 (USD MILLION) 139
7.3.1.2 Swine 139
7.3.1.2.1 Extensive use of infectious disease diagnostics as a response to epidemic outbreaks in this segment 139
TABLE 58 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE 140
TABLE 59 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE 140
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR SWINE,
BY COUNTRY, 2019–2026 (USD MILLION) 144
7.3.1.3 Poultry 144
7.3.1.3.1 The growth of this segment is driven by the growing poultry population and rising production volumes 144
TABLE 61 SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY 145
TABLE 62 SOME IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY 145
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY,
BY COUNTRY, 2019–2026 (USD MILLION) 148
7.3.1.4 Other food-producing animals 148
TABLE 64 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER FOOD -PRODUCING ANIMALS 149
TABLE 65 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 150
7.3.2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE 150
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 151
7.3.2.1 Bacterial infections 151
7.3.2.1.1 The bacterial infections segment accounted for the largest share of the food-producing animals market in 2020 151
TABLE 67 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS 152
TABLE 68 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION) 153
7.3.2.2 Viral infections 153
7.3.2.2.1 Need for early disease diagnosis and the rising awareness for viral infections to support the market growth 153
TABLE 69 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS 154
TABLE 70 VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 155
7.3.2.3 Parasitic infections 156
7.3.2.3.1 Worm infestations are a significant problem for pet & companion animal owners 156
TABLE 71 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS
IN FOOD-PRODUCING ANIMALS 156
TABLE 72 PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION) 157
7.3.2.4 Other infections 157
TABLE 73 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS 158
TABLE 74 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS
IN FOOD- PRODUCING ANIMALS 158
TABLE 75 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION) 159
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER 160
8.1 INTRODUCTION 161
TABLE 76 VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 161
8.2 VETERINARY REFERENCE LABORATORIES 161
8.2.1 VETERINARY REFERENCE LABORATORIES IS THE LARGEST
END USER SEGMENT 161
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 162
8.3 VETERINARY HOSPITALS & CLINICS 163
8.3.1 INCREASED PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH 163
FIGURE 33 US: PET INDUSTRY EXPENDITURE 163
FIGURE 34 ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS AND CATS 164
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 165
8.4 POINT-OF-CARE/ IN-HOUSE TESTING 165
8.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS 165
TABLE 79 KEY PRODUCTS OFFERED BY MARKET PLAYERS 166
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 167
8.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 167
8.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH 167
TABLE 81 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY,
2019–2026 (USD MILLION) 169
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION 170
9.1 INTRODUCTION 171
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION) 171
9.2 NORTH AMERICA 172
FIGURE 35 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA 173
FIGURE 36 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT 173
TABLE 83 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 174
TABLE 84 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 174
TABLE 85 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 174
TABLE 86 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 175
TABLE 87 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 175
TABLE 88 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 89 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 176
TABLE 90 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 91 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 176
TABLE 92 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 177
9.2.1 US 177
9.2.1.1 The US dominated the North American veterinary infectious disease diagnostics market in 2020 177
FIGURE 37 US: DOGS POPULATION, 2012–2020 (MILLION) 177
FIGURE 38 US: EXPENDITURE ON VET VISITS 178
TABLE 93 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 178
FIGURE 39 US: NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 (2020) 179
TABLE 94 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES,
2014–2019 179
TABLE 95 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 180
TABLE 96 US: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 180
TABLE 97 US: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 180
TABLE 98 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 181
TABLE 99 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 100 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 181
TABLE 101 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 102 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 182
TABLE 103 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 182
9.2.2 CANADA 183
9.2.2.1 Growing pet adoption in Canada to drive the market growth 183
FIGURE 40 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 183
TABLE 104 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 183
TABLE 105 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 184
TABLE 106 CANADA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 107 CANADA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 108 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 185
TABLE 109 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 110 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 185
TABLE 111 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 112 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 186
TABLE 113 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 186
9.3 EUROPE 187
TABLE 114 EUROPE: COMPANION POPULATION, 2019 (MILLION) 187
TABLE 115 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION) 187
FIGURE 41 EU-27: LIVESTOCK POPULATION, 2012-2019 (MILLION) 188
TABLE 116 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 189
TABLE 117 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 189
TABLE 118 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 189
TABLE 119 EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 120 EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 121 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 190
TABLE 122 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 123 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 191
TABLE 124 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 125 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION) 192
TABLE 126 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 192
9.3.1 GERMANY 192
9.3.1.1 Rising awareness regarding zoonotic diseases to drive the market growth in Germany 192
TABLE 127 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 193
TABLE 128 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 193
TABLE 129 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019 194
TABLE 130 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 194
TABLE 131 GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 194
TABLE 132 GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 195
TABLE 133 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 195
TABLE 134 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 135 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 196
TABLE 136 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 137 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION) 196
TABLE 138 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY END USER, 2019–2026 (USD MILLION) 197
9.3.2 UK 197
9.3.2.1 The UK is the fastest-growing market for veterinary infectious disease diagnostics in Europe 197
TABLE 139 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION) 197
TABLE 140 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 198
TABLE 141 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 198
TABLE 142 UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 199
TABLE 143 UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 199
TABLE 144 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 199
TABLE 145 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 146 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 200
TABLE 147 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 148 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 201
TABLE 149 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 201
9.3.3 FRANCE 201
9.3.3.1 France is one of the leading markets for companion pet ownership 201
TABLE 150 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 202
TABLE 151 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 202
TABLE 152 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 203
TABLE 153 FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 203
TABLE 154 FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 203
TABLE 155 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 204
TABLE 156 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 157 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 204
TABLE 158 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 159 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION) 205
TABLE 160 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY END USER, 2019–2026 (USD MILLION) 205
9.3.4 ITALY 206
9.3.4.1 Rising awareness about pet healthcare to propel the market growth for veterinary diagnostic products in Italy 206
TABLE 161 ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION) 206
TABLE 162 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 207
TABLE 163 ITALY: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 207
TABLE 164 ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 207
TABLE 165 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 208
TABLE 166 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 208
TABLE 167 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 208
TABLE 168 ITALY: VETERINARY DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 169 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 209
TABLE 170 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 209
9.3.5 SPAIN 210
9.3.5.1 Growing demand for pig & poultry products to support the adoption of veterinary diagnostic products in Spain 210
TABLE 171 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 210
TABLE 172 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 211
TABLE 173 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 211
TABLE 174 SPAIN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 211
TABLE 175 SPAIN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 176 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 212
TABLE 177 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 178 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 213
TABLE 179 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 180 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 213
TABLE 181 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 214
9.3.6 REST OF EUROPE 214
TABLE 182 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION) 214
TABLE 183 ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION) 215
TABLE 184 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
2010 VS. 2019 215
TABLE 185 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 215
TABLE 186 ROE: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 216
TABLE 187 ROE: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 216
TABLE 188 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 216
TABLE 189 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 190 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 217
TABLE 191 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 192 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 218
TABLE 193 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 218
9.4 ASIA PACIFIC 218
FIGURE 42 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT 219
TABLE 194 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 220
TABLE 195 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 220
TABLE 196 ASIA PACIFIC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 220
TABLE 197 ASIA PACIFIC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 221
TABLE 198 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 221
TABLE 199 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 200 ASIA PACIFIC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 222
TABLE 201 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 202 ASIA PACIFIC: FOOD-PRODUCING ANIMALS ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 222
TABLE 203 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 223
9.4.1 CHINA 223
9.4.1.1 China dominated the APAC veterinary infectious disease diagnostic market in 2020 223
TABLE 204 CHINA: LIVESTOCK POPULATION, 2010-2019 (MILLION) 224
TABLE 205 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 224
TABLE 206 CHINA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 225
TABLE 207 CHINA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 225
TABLE 208 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 225
TABLE 209 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 210 CHINA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 226
TABLE 211 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 212 CHINA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 227
TABLE 213 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 227
9.4.2 JAPAN 227
9.4.2.1 Rising awareness about zoonotic diseases and increasing pet expenditure to drive market growth 227
TABLE 214 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 228
TABLE 215 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 228
TABLE 216 JAPAN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 229
TABLE 217 JAPAN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 229
TABLE 218 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 229
TABLE 219 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 220 JAPAN: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 230
TABLE 221 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 222 JAPAN: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 231
TABLE 223 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 231
9.4.3 INDIA 231
9.4.3.1 India to become an untapped market with huge growth potential 231
TABLE 224 INDIA: LIVESTOCK POPULATION, 2007-2019 (MILLION) 232
TABLE 225 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 232
TABLE 226 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 233
TABLE 227 INDIA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 233
TABLE 228 INDIA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 233
TABLE 229 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 234
TABLE 230 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 231 INDIA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 234
TABLE 232 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 233 INDIA: FOOD- PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 235
TABLE 234 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 236
9.4.4 REST OF APAC 236
TABLE 235 REST OF APAC: LIVESTOCK POPULATION, BY COUNTRY,
2010-2019 (MILLION) 237
TABLE 236 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 238
TABLE 237 ROAPAC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 238
TABLE 238 ROAPAC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 238
TABLE 239 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 239
TABLE 240 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 239
TABLE 241 ROAPAC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 239
TABLE 242 ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 243 ROPAC: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 240
TABLE 244 ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 241
9.5 LATIN AMERICA 241
TABLE 245 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY,
2010-2019 (MILLION) 242
TABLE 246 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010 VS. 2019 242
TABLE 247 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 242
TABLE 248 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 243
TABLE 249 LATIN AMERICA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 243
TABLE 250 LATIN AMERICA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 243
TABLE 251 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 244
TABLE 252 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 244
TABLE 253 LATIN AMERICA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 244
TABLE 254 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 245
TABLE 255 LATIN AMERICA: FOOD-PRODUICNG ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 245
TABLE 256 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 246
9.5.1 BRAZIL 246
9.5.1.1 Brazil has the fourth-largest pet population in the world 246
TABLE 257 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 247
TABLE 258 BRAZIL: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 247
TABLE 259 BRAZIL: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 247
TABLE 260 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 248
TABLE 261 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 248
TABLE 262 BRAZIL: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 248
TABLE 263 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 264 BRAZIL: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 249
TABLE 265 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 249
9.5.2 MEXICO 250
9.5.2.1 Mexico is the second-largest pet care market in Latin America 250
TABLE 266 MEXICO: INCREASE IN LIVESTOCK POPULATION, 2010–2019 (MILLION) 250
TABLE 267 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 250
TABLE 268 MEXICO: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 251
TABLE 269 MEXICO: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 251
TABLE 270 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 251
TABLE 271 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 272 MEXICO: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 252
TABLE 273 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 274 MEXICO: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 253
TABLE 275 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 253
9.5.3 REST OF LATIN AMERICA 253
TABLE 276 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 254
TABLE 277 ROLA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 254
TABLE 278 ROLA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 254
TABLE 279 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 255
TABLE 280 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 255
TABLE 281 ROLA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 255
TABLE 282 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 256
TABLE 283 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 256
TABLE 284 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 256
9.6 MIDDLE EAST & AFRICA 257
9.6.1 MIDDLE EAST & AFRICA IS AN EMERGING MARKET FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PRODUCTS 257
TABLE 285 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION) 257
TABLE 286 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018 257
TABLE 287 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION) 258
TABLE 288 AFRICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS,
2010–2018 258
TABLE 289 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 258
TABLE 290 MEA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 259
TABLE 291 MEA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 259
TABLE 292 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 259
TABLE 293 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 260
TABLE 294 MEA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 260
TABLE 295 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 260
TABLE 296 MEA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION) 261
TABLE 297 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 261
10 COMPETITIVE LANDSCAPE 262
10.1 OVERVIEW 262
10.2 KEY PLAYER STRATEGIES/ RIGHT TO WIN 262
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 263
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 264
FIGURE 43 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 265
10.4 MARKET SHARE ANALYSIS 265
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE,
BY KEY PLAYER, 2020 266
TABLE 298 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEGREE
OF COMPETITION 266
10.5 COMPETITIVE LEADERSHIP MAPPING 268
10.5.1 STARS 268
10.5.2 EMERGING LEADERS 268
10.5.3 PERVASIVE PLAYERS 268
10.5.4 PARTICIPANTS 268
FIGURE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 269
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS 270
10.6.1 PROGRESSIVE COMPANIES 270
10.6.2 DYNAMIC COMPANIES 270
10.6.3 STARTING BLOCKS 270
10.6.4 RESPONSIVE COMPANIES 270
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2020) 271
10.7 COMPANY FOOTPRINT 272
TABLE 299 COMPANY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 272
10.7.1 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 273
TABLE 300 TECHNOLOGY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020) 273
10.7.2 ANIMAL FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 274
TABLE 301 ANIMAL TYPE FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020) 274
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 275
TABLE 302 END-USER FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020) 275
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 276
TABLE 303 GEOGRAPHIC FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020) 276
10.8 COMPETITIVE SCENARIO 277
10.8.1 PRODUCT LAUNCHES 277
TABLE 304 PRODUCT LAUNCHES, 2018–2021 277
10.8.2 DEALS 277
TABLE 305 DEALS, 2018–2021 277
10.8.3 OTHER DEVELOPMENTS 278
TABLE 306 OTHER DEVELOPMENTS, 2018–2021 278
11 COMPANY PROFILES 279
11.1 KEY PLAYERS 279
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 IDEXX LABORATORIES, INC. 279
TABLE 307 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW 279
FIGURE 47 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 280
11.1.2 ZEOTIS 290
TABLE 308 ZOETIS: BUSINESS OVERVIEW 290
FIGURE 48 ZOETIS: COMPANY SNAPSHOT (2020) 291
11.1.3 THERMO FISHER SCIENTIFIC INC. 296
TABLE 309 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 296
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 297
11.1.4 VIRBAC 307
TABLE 310 VIRBAC: BUSINESS OVERVIEW 307
FIGURE 50 VIRBAC: COMPANY SNAPSHOT (2020) 308
11.1.5 BIOMERIEUX S.A. 310
TABLE 311 BIOMERIEUX S.A.: BUSINESS OVERVIEW 310
FIGURE 51 BIOMERIEUX S.A.: COMPANY SNAPSHOT (2020) 311
11.1.6 HESKA CORPORATION 316
TABLE 312 HESKA CORPORATION: BUSINESS OVERVIEW 316
FIGURE 52 HESKA CORPORATION: COMPANY SNAPSHOT (2020) 317
11.1.7 IDVET 320
TABLE 313 IDVET: BUSINESS OVERVIEW 320
11.1.8 NEOGEN CORPORATION 328
TABLE 314 NEOGEN CORPORATION: BUSINESS OVERVIEW 328
FIGURE 53 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020) 329
11.1.9 QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE) 335
TABLE 315 QIAGEN N.V.: BUSINESS OVERVIEW 335
FIGURE 54 QIAGEN N.V.: COMPANY SNAPSHOT (2020) 336
11.1.10 RANDOX LABORATORIES LTD. 339
TABLE 316 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW 339
11.1.11 AGROLABO S.P.A. 341
TABLE 317 AGROLABO S.P.A.: BUSINESS OVERVIEW 341
11.1.12 BIONOTE USA INC. 352
TABLE 318 BIONOTE USA INC.: BUSINESS OVERVIEW 352
11.1.13 BIOGAL GALED LABS 355
TABLE 319 BIOGAL GALED LABS: BUSINESS OVERVIEW 355
11.1.14 BIOCHEK 357
TABLE 320 BIOCHEK: BUSINESS OVERVIEW 357
11.1.15 BIOPANDA REAGENTS LTD. 362
TABLE 321 BIOPANDA REAGENTS LTD.: BUSINESS OVERVIEW 362
11.1.16 URIT MEDICAL ELECTRONIC CO., LTD. 364
TABLE 322 URIT MEDICAL ELECTRONIC CO., LTD.: BUSINESS OVERVIEW 364
11.1.17 MEGACOR DIAGNOSTIK GMBH 366
TABLE 323 MEGACOR DIAGNOSTIK GMBH: BUSINESS OVERVIEW 366
11.1.18 BIO-RAD LABORATORIES, INC. 369
TABLE 324 BIO-RAD LABORATORIES: BUSINESS OVERVIEW 369
FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 370
11.1.19 LIVET 372
TABLE 325 LIVET: BUSINESS OVERVIEW 372
11.1.20 INDICAL BIOSCIENCE GMBH 373
TABLE 326 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW 373
11.2 OTHER PLAYERS 376
11.2.1 FASSISI, GMBH 376
11.2.2 ALVEDIA 377
11.2.3 SKYER, INC. 378
11.2.4 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 379
11.2.5 PRECISION BIOSENSOR 381
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 382
12.1 INSIGHTS FROM INDUSTRY EXPERTS 382
12.2 DISCUSSION GUIDE 383
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 389
12.4 AVAILABLE CUSTOMIZATIONS 391
12.5 RELATED REPORTS 391
12.6 AUTHOR DETAILS 392
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（診断薬）の最新刊レポート
MarketsandMarkets 社の最新刊レポート
本レポートと同じKEY WORD（clinics）の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/19 10:28 144.64 円 160.77 円 193.27 円 |
